Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1223957A4 A method of treating erectile dysfunction
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1051194B1 Process for making absorbable microparticles
05/14/2003EP1041996A4 Keratinocyte growth factor-2 formulations
05/14/2003EP1036095A4 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
05/14/2003EP0979096B1 Treatment of infarcts through inhibition of nf-kappab
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0846682B9 Penicillaminamide derivatives
05/14/2003EP0833902B1 Oligonucleotides specific for hepatitis c virus
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003EP0783319B1 Muramyl peptide compositions for inhibiting hiv replication
05/14/2003EP0753065B1 Antibodies against e-selectin
05/14/2003EP0731710B1 Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease
05/14/2003EP0672141B1 Methods of preparing soluble, oligomeric proteins
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003EP0550450B1 Use of crosslinked crystals as a novel form of enzyme immobilization
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418223A Novel human hepatoma associated protein and coding sequence thereof
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418113A medicinal aerosol formulation
05/14/2003CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
05/14/2003CN1418108A Parenteral use of bacterial phage associated lysing enzymes for therapeutic treatment of bacterial infections
05/14/2003CN1418107A Use of FSH for treating infertility
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1417229A Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition
05/14/2003CN1417228A Fluorescent phycocyanin and fluorescent phycoerythrin and their application
05/14/2003CN1416914A Artificial biological canula and its making process
05/14/2003CN1416896A Tumor CT antigen immune inducing agent for treating liver cancer and its prepn
05/14/2003CN1416895A Slow releasing microballoon injection of fish mature accelerating hormone and its prepn
05/14/2003CN1416894A Secreted recombinant human interferon alpha-2a injection liquid
05/14/2003CN1416893A Medicine containing recombinant human metallothionein and its prepn
05/14/2003CN1108170C Buffering liquid for staphylococcus Aureus Injection and stephylococcus Aureus Injection with buffering liquid
05/14/2003CN1108169C Medicinal composition of polypeptide for treating radiation damage
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562949 Antibody for use in the treatment of inflammation and inflammatory ddisorders
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562943 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
05/13/2003US6562942 Peptide for use in the prevention and treatment of diabetes
05/13/2003US6562852 Streptogramin derivatives, their preparation and compositions which contain them
05/13/2003US6562848 For treating HIV infection, comprising: administering claimed compound with at least one compound selected from the group consisting of HIV reverse transcriptase inhibitors and HIV protease inhibitors
05/13/2003US6562820 Method for treatment and prevention of mastitis
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562792 Hygromycin derivatives
05/13/2003US6562790 Administering a combination of natural hormones including human growth hormone with sufficient T3 thyroid supplement to maintain the body temperature of the subject at or above 97.6 degrees F. upon awakening and at 98.7 degrees F
05/13/2003US6562788 Novel class of peptide inhibitors of topoisomerase II chemotherapeutic antitumor agents
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562786 Compounds and methods for modulating apoptosis
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562782 Oligocycloalkanoid compounds and methods of use
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562606 Methods and compositions for disrupting the epithelial barrier function
05/13/2003US6562598 Factor X deletion mutants and analogues thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562595 Nucleic acids; fungicides
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562592 Nucleotide sequencs coding membrane protein for use in the treatment and prevention of bone, cardiovascular, cancer or central nervous system disorders
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562588 Sialidase and recombinant cell lines
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562579 Diagnosing autoimmune disease; obtain sample, incubate with antibody, determine the concentration of preferential cytokine protein in sample, comparing to control, adjustment in cytokine concentration indicates autoimmune disease
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562379 Administering lectin
05/13/2003US6562366 Method to prevent the formation and enhance the breakdown of bezoars in animals and humans
05/13/2003US6562358 Nontoxic vernix compositions and method of producing
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562344 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562342 Preventives/remedies for inflammatory intestinal disease
05/13/2003US6562339 Composition and method for lactose hydrolysis
05/13/2003US6562338 Composition and method for lactose hydrolysis
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003US6562334 Canine interleukin 12 administration as an immune disease treatment
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003CA2315877C Facilitated oxygen delivery in conjunction with hemodilution
05/13/2003CA2138975C Topical application composition
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/08/2003WO2003038441A2 Screening methods based on cited family proteins
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038112A2 A composition and method to alter lean body mass and bone properties in a subject
05/08/2003WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038079A2 A mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
05/08/2003WO2003038063A2 Human secreted proteins
1 ... 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 ... 3163